Triamcinolone acetonide+ salicylic acid in cetomacrogol

Generic name
Triamcinolone acetonide+ salicylic acid in cetomacrogol
Brand name
ATC Code
D07XB02

Triamcinolone acetonide+ salicylic acid in cetomacrogol

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information is present at this moment.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Contraindicated
  • Route of administration not applicable
    • 0 years up to 18 years
      • Preparations with salicylic acid for application to the skin (other than for warts) are contraindicated in children due to risk of salicylism. For this reason, triamcinolone + salicylic acid is no longer included in the paediatric formulary.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

CORTICOSTEROIDS, OTHER COMBINATIONS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Corticosteroids, moderately potent, other combinations
D07XB01

References

Changes

Therapeutic Drug Monitoring


Overdose